Transfusion-transmitted leishmaniasis: A practical review

Transfusion

Volumn 56, Issue , 2016, Pages S45-S51

  Jimenez Marco, Teresa ^a,b   Fisa, Roser ^c   Girona Llobera, Enrique ^a,b   Cancino Faure, Beatriz ^c   Tomás Pérez, Miriam ^c   Berenguer, Diana ^c   Guillen, Carmen ^c   Pujol, Alba ^c   Iniesta, Laura ^c   Serra, Teresa ^b   Mascaró, Martín ^d   Gascó, Joan ^e   Riera, Cristina ^c  

^a Fundacio Banc de Sang i Teixits   (Spain)

^b Institut Universitari d'Investigació en Ciències de La Salut IUNICS   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL SON LLÀTZER   (Spain)

^e HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; HUMAN; IATROGENIC DISEASE; INFECTION RISK; LEISHMANIASIS; TRANSFUSION TRANSMITTED LEISHMANIASIS; BLOOD; BLOODBORNE BACTERIUM; FEMALE; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; RISK FACTOR; SPAIN; TRANSMISSION;

BLOOD DONORS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; FEMALE; HUMANS; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; RISK FACTORS; SPAIN;

EID: 84961827227     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13344     Document Type: Article

References (40)

1. Control of the Leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. WHO Technical Report Series, No. 949. Geneva: World Health Organization; 2010.
2. Chung HL, Chow KK, Lu JP., The first two cases of transfusion kala-azar. Chin Med J 1948; 66: 325-6.
3. Andre R, Brumpt L, Dreytus B, et al., Leishmaniose cutanee. Leishmaniose cutanee ganglionnare et kala-azar transfusional. Trop Dis Bull 1958; 55: 379-81.
4. Kostman R, Barr M, Bengtson E, et al., Kala-azar transferred by exchange blood transfusion in two Swedish infants. In: Proceedings of the 7th International Congress of Tropical Medicine and Malaria. Geneva: World Health Organization; 1963. p. 384.
5. Cohen C, Corazza F, De Mol P, et al., Leishmaniasis acquired in Belgium. Lancet 1991; 338: 128.
6. Cummins D, Amin S, Halil O, et al., Visceral leishmaniasis after cardiac surgery. Arch Dis Child 1995; 72: 235-6.
7. Singh S, Chaudhry VP, Wali JP., Transfusion-transmitted kala-azar in India. Transfusion 1996; 36: 848-9.
8. Mathur P, Samantaray JC., The first probable case of platelet transfusion-transmitted visceral leishmaniasis. Transfus Med 2004; 14: 319-21.
9. Dey A, Singh S., Transfusion transmitted leishmaniasis: a case report and review of literature. Indian J Med Microbiol 2006; 24: 165-70.
10. Mpaka MA, Daniil Z, Kyriakou DS, et al., Septic shock due to visceral leishmaniasis, probably transmitted from blood transfusion. J Infect Dev Ctries 2009; 3: 479-83.
11. Mestra L, Lopez L, Robledo SM, et al., Transfusion-transmitted visceral leishmaniasis caused by Leishmania (Leishmania) mexicana in an immunocompromised patient: a case report. Transfusion 2011; 51: 1919-23.
12. Luz KG, da Silva VO, Gomes EM, et al., Prevalence of anti-Leishmania donovani antibody among Brazilian blood donors and multiply transfused hemodialysis patients. Am J Trop Med Hyg 1997; 57: 168-71.
13. Mansueto P, Seidita A, Vitale G, et al., Transfusion transmitted leishmaniasis. What to do with blood donors from endemic areas? Travel Med Infect Dis 2014; 12: 617-27.
14. Riera C, Fisa R, López-Chejade P, et al., Asymptomatic infection by Leishmania infantum in blood donors from the Balearic Islands (Spain). Transfusion 2008; 48: 1383-9.
15. Le Fichoux Y, Quaranta JF, Aufeuvre JP, et al., Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France. J Clin Microbiol 1999; 37: 1953-7.
16. Mary C, Lamouroux D, Dunan S, et al., Western blot analysis of antibodies to Leishmania infantum antigens: potential of the 14-kD and 16-kD antigens for diagnosis and epidemiologic purposes. Am J Trop Med Hyg 1992; 47: 764-71.
17. Pampiglione S, Manson-Bahr PE, La Placa M, et al., Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar. Trans R Soc Trop Med Hyg 1975; 69: 60-8.
18. Gramiccia M, Bettini S, Gradoni L, et al., Leishmaniasis in Sardinia. 5. Leishmanin reaction in the human population of a focus of low endemicity of canine leishmaniasis. Trans R Soc Trop Med Hyg 1990; 84: 371-4.
19. Marty P, Lelievre A, Quaranta JF, et al., Use of the leishmanin skin test and Western blot analysis for epidemiological studies in visceral leishmaniasis areas: experience in a highly endemic focus in Alpes-Maritimes (France). Trans R Soc Trop Med Hyg 1994; 88: 658-9.
20. Cardenosa N, Riera C, Cortes P, et al., Detection and characterization by immunoblot analysis of potentially diagnostic Leishmania infantum polypeptides in human visceral leishmaniasis. Parasite Immunol 1995; 17: 509-16.
21. Acedo-Sanchez C, Martín Sanchez J, Velez Bernal ID, et al., Leishmaniasis eco-epidemiology in the Alpujarra region (Granada Province, southern Spain). Int J Parasitol 1996; 26: 303-10.
22. Moral L, Rubio EM, Moya M., A leishmanin skin test survey in the human population of L'Alacantí region (Spain): implications for the epidemiology of Leishmania infantum infection in southern Europe. Trans R Soc Trop Med Hyg 2002; 96: 129-32.
23. Kyriakou DS, Alexandrakis MG, Passam FH, et al., Quick detection of Leishmania in peripheral blood by flow cytometry. Is prestorage leucodepletion necessary for leishmaniasis prevention in endemic areas? Transfus Med 2003; 13: 59-62.
24. Pérez-Cutillas P, Goyena E, Chitimia L, et al., Spatial distribution of human asymptomatic Leishmania infantum infection in southeast Spain: a study of environmental, demographic and social risk factors. Acta Trop 2015; 146: 127-34.
25. Otero AC, Da Silva VO, Luz KG, et al., Short report: occurrence of Leishmania donovani DNA in donated blood from seroreactive Brazilian blood donors. Am J Trop Med Hyg 2002; 62: 128-31.
26. Michel G, Pomares C, Ferrua B, et al., Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human. Acta Trop 2011; 119: 69-75.
27. Pitta M, Romano A, Cabantous S, et al., IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J Clin Invest 2009; 119: 2379-87.
28. Nascimiento MS, Carregaro V, Lima-Júnior DS, et al., Interleukin 17A acts synergistically with interferon γ to promote protection against Leishmania infantum infection. J Infect Dis 2015; 211: 1015-26.
29. Costa CH, Stewart JM, Gomes RB, et al., Asymptomatic human carriers of Leishmania chagasi. Am J Trop Med Hyg 2002; 66: 334-7.
30. Riera C, Fisa R, Udina M, et al., Detection of Leishmania infantum cryptic infection in asymptomatic blood donors living in an endemic area (Eivissa, Balearic Islands, Spain) by different diagnostic methods. Trans R Soc Trop Med Hyg 2004; 98: 102-10.
31. Mary C, Faraut F, Drogoul MP, et al., Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up. Am J Trop Med Hyg 2006; 75: 858-63.
32. National Healthcare Safety Network imputability criteria [Internet]. Atlanta (GA): Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention; 2014 [cited 2015 May 21]. Available from: http://www.cdc.gov/nhsn/PDFs/Biovigilance/BV-HV-protocol-current.pdf
33. Jimenez-Marco T, Riera C, Fisa R, et al., A possible case of transfusion-transmitted visceral leishmaniasis. Transfusion 2012; 52: 1154-5.
34. Spanish Accreditation Committee on Transfusion. Accreditation standards for blood transfusion. 4th ed. Barcelona: Spanish Association of Haematology and Hemotherapy, Spanish Society of Blood Transfusion; 2012. Available from: www.catransfusion.es/
35. Cardo LJ, Rentas FJ, Ketchum L, et al., Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang 2006; 90: 85-91.
36. Jimenez-Marco T, Riera C, Fisa R, et al., The utility of pathogen inactivation technology: a real-life example of Leishmania infantum inactivation in platelets from a donor with an asymptomatic infection. Blood Transfus 2012; 10: 536-41.
37. Eastman RT, Barrett LK, Dupuis K, et al., Leishmania inactivation in human pheresis platelets by a psoralen (amotosalen HCl) and long wavelength ultraviolet irradiation. Transfusion 2005; 45: 1459-63.
38. Jimenez-Marco T, Fisa R, Riera C, et al., Pathogen inactivation technology applied to a blood component collected from an asymptomatic carrier of Leishmania infantum: a case report. Vox Sang 2012; 103: 356-8.
39. Wagner SJ, Skripchenko A, Salata J, et al., Photoinactivation of Leishmania donovani infantum in red cell suspensions by a flexible thiopyrylium sensitizer. Vox Sang 2006; 91: 178-80.
40. Tonnetti L, Thorp AM, Reddy HL, et al., Reduction of Leishmania donovani infectivity in whole blood using riboflavin and ultraviolet light. Transfusion 2015; 55: 326-9.